MedTrace Logo

Platelet Rich Plasma to Treat Plantar Fasciitis

NCT00758641 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2017-03-14

No results posted yet for this study

Summary

Rationale: The standard treatment of chronic plantar fasciitis is corticosteroid injections. Corticosteroid injection give temporarily pain reduction, but no healing. Blood platelets initiate the natural healing rate. GPS ® gives an eightfold concentrate platelets of patients own blood. Injection of these platelets in the tendon might induce a healing rate.

Objective: To compare the efficacy of autologous platelet concentrate injections with corticosteroid injection in patients suffering from plantar fasciitis with respect to pain and function.

Conditions

  • Plantar Fasciitis

Interventions

DEVICE

L-PRP Injection

L-PRP produced with Biomet Recover L-PRP Platelet Separation Kit

DRUG

Corticosteroid Injection

kenacort 40 mg/ml triamcinolon acetonide

Sponsors & Collaborators

  • Elisabeth-TweeSteden Ziekenhuis

    collaborator OTHER

  • Diaconessenhuis Leiden Netherlands

    collaborator UNKNOWN

  • Biomet Nederland BV

    collaborator INDUSTRY

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • T Gosens, MD, PhD · St Elisabeth Hospital

  • H.M. Schuller, PhD, MD · Diaconessehuis Leiden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00758641 on ClinicalTrials.gov